Related Experiment Video
Updated: Dec 6, 2025
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
Alip Ghosh1, Sara Romani1, Shyam Kottilil1
1Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Insights
Direct-acting antiviral treatments can cure chronic hepatitis C (CHC) infection. However, research is ongoing to understand how viral clearance impacts immune system recovery and protection against reinfection.
Area of Science:
- Hepatology
- Immunology
- Virology
Background:
- Chronic hepatitis C (CHC) is a significant global health concern.
- Direct-acting antiviral (DAA) agents offer a curative treatment for CHC, achieving high sustained virologic response (SVR) rates.
- The long-term effects of DAA treatment on immune system recovery and liver pathology are still under investigation.
Purpose of the Study:
- To review the current literature on immune system dysregulation in CHC patients.
- To examine the status of lymphocyte populations after DAA-induced viral clearance.
- To discuss the implications of immune reconstitution for preventing HCV reinfection and reducing liver disease progression.
Main Methods:
- Literature review of studies investigating immune defects in CHC patients.
- Analysis of lymphocyte populations before and after DAA treatment.
- Synthesis of findings on immune homeostasis restoration and its consequences.
Main Results:
- Patients with CHC exhibit significant immune dysregulation, particularly in lymphocyte populations.
- DAA treatment leads to viral clearance and SVR in most patients.
- The extent and timeline of immune system normalization post-cure require further investigation.
Conclusions:
- While DAA treatments are highly effective in curing CHC, the long-term impact on immune function and protection against reinfection remains a critical area of research.
- Understanding immune recovery is crucial for managing patients post-cure and for developing effective prophylactic strategies, such as vaccines.
- Further studies are needed to elucidate the consequences of persistent immune defects and to determine the impact of viral clearance on reducing liver pathology and hepatocellular carcinoma risk.
Abstract:
Chronic HCV (CHC) infection is the only chronic viral infection for which curative treatments have been discovered. These direct acting antiviral (DAA) agents target specific steps in the viral replication cycle with remarkable efficacy and result in sustained virologic response (SVR) or cure in high (>95%) proportions of patients. These treatments became available 6-7 years ago and it is estimated that their real impact on HCV related morbidity, including outcomes such as cirrhosis and hepatocellular carcinoma (HCC), will not be known for the next decade or so. The immune system of a chronically infected patient is severely dysregulated and questions remain regarding the immune system's capacity in limiting liver pathology in a cured individual. Another important consequence of impaired immunity in patients cleared of HCV with DAA will be the inability to generate protective immunity against possible re-infection, necessitating retreatments or developing a prophylactic vaccine. Thus, the impact of viral clearance on restoring immune homeostasis is being investigated by many groups. Among the important questions that need to be answered are how much the immune system normalizes with cure, how long after viral clearance this recalibration occurs, what are the consequences of persisting immune defects for protection from re-infection in vulnerable populations, and does viral clearance reduce liver pathology and the risk of developing hepatocellular carcinoma in individuals cured with these agents. Here, we review the recent literature that describes the defects present in various lymphocyte populations in a CHC patient and their status after viral clearance using DAA treatments.
More Related Videos
Related Concept Videos
01:18Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
01:16Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:15Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...